Squarepoint’s Utah Medical Products UTMD Stock Holding History

Squarepoint’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$211K	Buy	+2,853	New	+$203K	﹤0.01%	4031
2024 Q2	–	Sell	-9,398	Closed	-$668K	–	4686
2024 Q1	$668K	Buy	+9,398	New	+$705K	﹤0.01%	2858
2023 Q3	–	Sell	-3,226	Closed	-$301K	–	4274
2023 Q2	$301K	Buy	+3,226	New	+$304K	﹤0.01%	2973
2021 Q2	–	Sell	-2,714	Closed	-$235K	–	3722
2021 Q1	$235K	Buy	+2,714	New	+$239K	﹤0.01%	2594
2020 Q1	–	Sell	-3,143	Closed	-$339K	–	2548
2019 Q4	$339K	Sell	3,143 -4,829	-61%	-$489K	﹤0.01%	1977
2019 Q3	$764K	Buy	7,972 +5,472	+219%	+$509K	0.01%	1401
2019 Q2	$239K	Buy	+2,500	New	+$210K	﹤0.01%	2035

Other funds holding UTMD

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Cardinal Capital Management Inc (North Carolina) Raleigh, North Carolina $861M AUM 27.19% 1-Year Est. Return

O'Shaughnessy Asset Management Stamford, Connecticut $23.6B AUM 34.05% 1-Year Est. Return

Everett Harris & Co Los Angeles, California $8.46B AUM 13.48% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Squarepoint's UTMD Position: Q3 2026 in Review

Squarepoint opened a new position in Utah Medical Products (UTMD) in Q3 2026: 2,853 shares worth $211K. The stake represents ﹤0.01% of the portfolio and ranks #4031 among its holdings. This is a return to the name: Squarepoint previously reported a position in UTMD as recently as Q1 2024.

Squarepoint first reported a position in UTMD in Q2 2019 and has held it in 7 quarters since. The position peaked at $764K in Q3 2019. 74 funds tracked by Wall St. Rank hold UTMD as of Q3 2026.

Squarepoint held 2,853 shares of Utah Medical Products worth $211K as of Q3 2026.
Utah Medical Products was a new Squarepoint position in Q3 2026.
Utah Medical Products made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #4031 holding.
Squarepoint first reported a position in Utah Medical Products in Q2 2019 and has held it in 7 quarters since.
Squarepoint's Utah Medical Products position peaked at $764K in Q3 2019.
74 funds tracked by Wall St. Rank held Utah Medical Products as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.